{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:37:22Z","timestamp":1793317042283,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejmech.2022.114190","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T10:54:56Z","timestamp":1644663296000},"page":"114190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach"],"prefix":"10.1016","volume":"232","author":[{"given":"Haytham O.","family":"Tawfik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Petreni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervat H.","family":"El-Hamamsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114190_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbapap.2009.07.027","article-title":"Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target","volume":"1804","author":"De Simone","year":"2010","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.ejmech.2022.114190_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2020.112923","article-title":"Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors","volume":"209","author":"Kumar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib3","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/14756366.2021.1972995","article-title":"An overview on the recently discovered iota-carbonic anhydrases","volume":"36","author":"Nocentini","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114190_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14756366.2018.1524380","article-title":"Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line","volume":"34","author":"Koyuncu","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114190_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2022.114190_bib8","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4155\/fmc-2021-0222","article-title":"Novel carbonic anhydrase inhibitors","volume":"13","author":"Supuran","year":"2021","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib9","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII","volume":"17","author":"Guler","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib10","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M800938200","article-title":"Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes","volume":"283","author":"Hilvo","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib11","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/jm500255y","article-title":"Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes","volume":"57","author":"Moeker","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejmech.2022.114190_bib13","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1158\/1078-0432.CCR-06-0480","article-title":"CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance","volume":"12","author":"Brennan","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114190_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.urology.2007.06.1118","article-title":"Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization","volume":"70","author":"Anai","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.ejmech.2022.114190_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.radonc.2013.06.018","article-title":"Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs","volume":"108","author":"Dubois","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2022.114190_bib16","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1021\/jm060531j","article-title":"Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX","volume":"49","author":"De Simone","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib17","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1021\/jm4009532","article-title":"Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides\/sulfamides\/sulfamates","volume":"56","author":"Rami","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib18","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1080\/14756366.2020.1825409","article-title":"An overview of carbohydrate-based carbonic anhydrase inhibitors","volume":"35","author":"Cuffaro","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2021.113283","article-title":"Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"216","author":"Shaldam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2019.103102","article-title":"Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity","volume":"90","author":"Eldehna","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","article-title":"Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: selective inhibitors for the tumor-associated hCA IX isoform","volume":"152","author":"Ibrahim","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib22","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.111768","article-title":"3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: synthesis, in\u00a0vitro biological evaluation and in silico insights","volume":"184","author":"Abo-Ashour","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bioorg.2018.07.027","article-title":"Synthesis of novel isoindoline-1, 3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX","volume":"80","author":"Alaa","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molstruc.2020.128966","article-title":"Novel adamantane-pyrazole and hydrazone hybridized: design, synthesis, cytotoxic evaluation, SAR study and molecular docking simulation as carbonic anhydrase inhibitors","volume":"1223","author":"Wassel","year":"2021","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.114190_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/14756366.2019.1697250","article-title":"Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in\u00a0vitro biological evaluation","volume":"35","author":"Abdelrahman","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20092354","article-title":"Indole-based hydrazones containing A sulfonamide moiety as selective inhibitors of tumor-associated human carbonic anhydrase isoforms IX and XII","volume":"20","author":"Demir-Yaz\u0131c\u0131","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114190_bib28","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","article-title":"Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII","volume":"24","author":"Chandak","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2021.111851","article-title":"The bioactivity of benzenesulfonyl hydrazones: a short review","volume":"141","author":"Popio\u0142ek","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.114190_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2020.103658","article-title":"Synthesis and structure\u2013affinity relationship of chlorinated pyrrolidinone-bearing benzenesulfonamides as human carbonic anhydrase inhibitors","volume":"97","author":"Balandis","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2019.06.081","article-title":"Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic\/phobic tails for targeting the middle region of human carbonic anhydrases active site: selective inhibitors of hCA IX","volume":"179","author":"Allam","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejmech.2015.09.021","article-title":"Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII","volume":"103","author":"Ibrahim","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.111843","article-title":"Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors","volume":"185","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bioorg.2018.10.037","article-title":"4-Substituted benzenesulfonamides featuring cyclic imides moieties exhibit potent and isoform-selective carbonic anhydrase II\/IX inhibition","volume":"83","author":"Abdel-Aziz","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bioorg.2017.08.017","article-title":"N-Sulfamoylphenyl- and N-sulfamoylphenyl-N-thiazolyl-\u03b2-alanines and their derivatives as inhibitors of human carbonic anhydrases","volume":"75","author":"Va\u0161kevi\u010dien\u0117","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms222011283","article-title":"Synthesis and inhibition activity study of triazinyl-substituted amino(alkyl)-benzenesulfonamide conjugates with polar and hydrophobic amino acids as inhibitors of human carbonic anhydrases I, II, IV, IX, and XII","volume":"22","author":"Mikulov\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114190_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.06.022","article-title":"Probing the \u2018bipolar\u2019 nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms","volume":"101","author":"Krasavin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib38","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2021.113486","article-title":"Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail\/dual tail approaches: synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"221","author":"Eldeeb","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.03.023","article-title":"Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site","volume":"132","author":"Hou","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2020.112897","article-title":"Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: synthesis, biological and molecular dynamics analysis","volume":"209","author":"Abdelrahman","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2021.113351","article-title":"Comprehensive study on potent and selective carbonic anhydrase inhibitors: synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides","volume":"217","author":"Yamali","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bioorg.2017.03.014","article-title":"Carbohydrazones as new class of carbonic anhydrase inhibitors: synthesis, kinetics, and ligand docking studies","volume":"72","author":"Iqbal","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bioorg.2019.02.008","article-title":"Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes","volume":"86","author":"Kucukoglu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2021.104669","article-title":"Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors","volume":"108","author":"Sayed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molstruc.2017.11.087","article-title":"Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine-quinazolinone based hybrids","volume":"1156","author":"Dinari","year":"2018","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.114190_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jhet.5570450236","article-title":"An efficient, \u201cgreen\u201d approach to aryl amination of cyanuric chloride using acetic acid as solvent","volume":"45","author":"Kolmakov","year":"2008","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molstruc.2016.05.064","article-title":"Microwave assisted regioselective synthesis and 2D-NMR studies of novel azoles and azoloazines utilizing fluorine-containing building Blocks","volume":"1121","author":"Al-Bogami","year":"2016","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.114190_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2020.104189","article-title":"Design, synthesis and biological evaluation of novel (E)-N-phenyl-4-(pyridine-acylhydrazone) benzamide derivatives as potential antitumor agents for the treatment of multiple myeloma (MM)","volume":"103","author":"Li","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmcl.2019.126630","article-title":"Design, synthesis, and biological evaluation of 4-((6,7-dimethoxyquinoline-4-yl)oxy)aniline derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemia","volume":"29","author":"Xu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114190_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2019.103514","article-title":"Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII","volume":"95","author":"George","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib52","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.bmc.2014.05.009","article-title":"Carbonic anhydrase inhibitors: synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties","volume":"22","author":"Ghorab","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","article-title":"Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents","volume":"162","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib54","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1021\/acs.jmedchem.8b01504","article-title":"4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles","volume":"61","author":"Nocentini","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms222011119","article-title":"Development of novel quinoline-based sulfonamides as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"22","author":"Shaldam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114190_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2019.103153","article-title":"Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives","volume":"91","author":"Sa\u011fl\u0131k","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib57","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.bmc.2012.08.019","article-title":"Insights towards sulfonamide drug specificity in \u03b1-carbonic anhydrases","volume":"21","author":"Aggarwal","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib58","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1016\/j.bmc.2013.08.033","article-title":"Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases","volume":"21","author":"Pinard","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2019.103406","article-title":"Anticancer, antimicrobial activities of quinoline based hydrazone analogues: synthesis, characterization and molecular docking","volume":"94","author":"Katariya","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","article-title":"Some practical considerations and applications of the National Cancer Institute in\u00a0vitro anticancer drug discovery screen","volume":"34","author":"Boyd","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2022.114190_bib61","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.arabjc.2015.08.019","article-title":"Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents","volume":"12","author":"Rashid","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2016.03.088","article-title":"Synthesis and in\u00a0vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin","volume":"117","author":"Singla","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25204833","article-title":"Evaluation of cytotoxicity and \u03b1-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids","volume":"25","author":"Kazakova","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114190_bib64","doi-asserted-by":"crossref","first-page":"18656","DOI":"10.3390\/molecules191118656","article-title":"Synthesis and in\u00a0vitro antitumor activity of a novel series of 2-pyrazoline derivatives bearing the 4-Aryloxy-7-chloroquinoline fragment","volume":"19","author":"Montoya","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114190_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2021.113997","article-title":"Synthesis, biological evaluation, and in silico studies of potential activators of apoptosis and carbonic anhydrase inhibitors on isatin-5-sulfonamide scaffold","volume":"228","author":"Krymov","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib66","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.abb.2018.01.012","article-title":"Promoter analysis and transcriptional regulation of human carbonic anhydrase VIII gene in a MERRF disease cell model","volume":"641","author":"Lo","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2022.114190_bib67","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1080\/14756366.2021.1924698","article-title":"Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study","volume":"36","author":"Abdel-Aziz","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114190_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A\u00a0novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2022.114190_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20102484","article-title":"Novel diamide-based benzenesulfonamides as selective carbonic anhydrase IX inhibitors endowed with antitumor activity: synthesis, biological evaluation and in silico insights","volume":"20","author":"Abdelrahman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114190_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep46056","article-title":"Oxoaporphine metal complexes (Co II, Ni II, Zn II) with high antitumor activity by inducing mitochondria-mediated apoptosis and S-phase arrest in HepG2","volume":"7","author":"Qin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114190_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21070934","article-title":"Protocatechualdehyde Induces S-Phase arrest and apoptosis by stimulating the p27KIP1-Cyclin A\/D1-CDK2 and mitochondrial apoptotic pathways in HT-29 Cells","volume":"21","author":"Zhong","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114190_bib73","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jbt.22203","article-title":"7, 8-Dihydroxy-3-(4-nitrophenyl) coumarin induces cell death via reactive oxygen species\u2013independent S-phase cell arrest","volume":"32","author":"Musa","year":"2018","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114190_bib74","doi-asserted-by":"crossref","first-page":"26241","DOI":"10.1039\/D1RA05277B","article-title":"Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition","volume":"11","author":"Nemr","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2022.114190_bib75","doi-asserted-by":"crossref","first-page":"29441","DOI":"10.1039\/D1RA04758B","article-title":"New pyridine and chromene scaffolds as potent vasorelaxant and anticancer agents","volume":"11","author":"Dawood","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2022.114190_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471142727.mb2806s111","article-title":"Assaying cell cycle status using flow cytometry","volume":"111","author":"Kim","year":"2015","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114190_bib77","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejmech.2022.114190_bib78","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1039\/C4AY00288A","article-title":"Measurement of DCF fluorescence as a measure of reactive oxygen species in murine islets of Langerhans","volume":"6","author":"Wang","year":"2014","journal-title":"Anal. Methods"},{"key":"10.1016\/j.ejmech.2022.114190_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22115642","article-title":"Incorporation of sulfonamide moiety into biguanide scaffold results in apoptosis induction and cell cycle arrest in MCF-7 breast cancer cells","volume":"22","author":"Markowicz-Piasecka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114190_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/453543","article-title":"Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors","author":"Pinard","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2022.114190_bib81","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/14756360009040713","article-title":"Carbonic anhydrase inhibitors: aromatic sulfonamides and disulfonamides act as efficient tumor growth inhibitors","volume":"15","author":"Supuran","year":"2000","journal-title":"J.\u00a0Enzym. Inhib."},{"key":"10.1016\/j.ejmech.2022.114190_bib82","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3109\/14756366.2015.1069288","article-title":"Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies","volume":"31","author":"Abdel-Aziz","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib83","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/14756366.2021.2004592","article-title":"Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines","volume":"37","author":"Mussi","year":"2022","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2022.114190_bib85","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/14756366.2017.1421181","article-title":"Novel [(3-indolylmethylene) hydrazono] indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in\u00a0vitro biological evaluation","volume":"33","author":"Eldehna","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.112019","article-title":"Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: design, synthesis, and in\u00a0vitro biological evaluation","volume":"189","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib87","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/14756366.2017.1417276","article-title":"One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells","volume":"33","author":"Eldehna","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib88","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bioorg.2018.03.027","article-title":"Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes","volume":"78","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114190_bib89","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/molecules20022323","article-title":"Targeting carbonic anhydrase IX activity and expression","volume":"20","author":"Mahon","year":"2015","journal-title":"Molecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:40:12Z","timestamp":1759329612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422000927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":89,"alternative-id":["S0223523422000927"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114190","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114190"}}